PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 186 filers reported holding PDL BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $190,000 | +8.6% | 77,100 | 0.0% | 0.00% | – |
| Q1 2017 | $175,000 | +7.4% | 77,100 | 0.0% | 0.00% | – |
| Q4 2016 | $163,000 | -36.8% | 77,100 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $258,000 | +789.7% | 77,100 | +720.2% | 0.00% | – |
| Q2 2016 | $29,000 | -99.1% | 9,400 | -99.0% | 0.00% | -100.0% |
| Q1 2016 | $3,053,000 | -30.7% | 917,000 | -26.3% | 0.01% | -40.0% |
| Q4 2015 | $4,406,000 | -35.4% | 1,244,800 | -8.3% | 0.01% | -33.3% |
| Q3 2015 | $6,824,000 | -21.8% | 1,356,800 | 0.0% | 0.02% | -16.7% |
| Q2 2015 | $8,724,000 | -26.9% | 1,356,800 | -20.0% | 0.02% | -28.0% |
| Q1 2015 | $11,927,000 | -13.9% | 1,695,483 | -5.6% | 0.02% | -13.8% |
| Q4 2014 | $13,846,000 | +2.7% | 1,795,883 | -0.5% | 0.03% | -3.3% |
| Q3 2014 | $13,481,000 | -28.6% | 1,804,783 | -7.4% | 0.03% | -28.6% |
| Q2 2014 | $18,875,000 | +15.2% | 1,949,983 | -1.1% | 0.04% | +10.5% |
| Q1 2014 | $16,388,000 | -4.1% | 1,972,083 | -2.6% | 0.04% | -5.0% |
| Q4 2013 | $17,083,000 | +3.8% | 2,024,083 | -2.0% | 0.04% | -4.8% |
| Q3 2013 | $16,465,000 | +3.8% | 2,065,883 | +0.5% | 0.04% | 0.0% |
| Q2 2013 | $15,866,000 | – | 2,055,300 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |